Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,168,524 papers from all fields of science
Search
Sign In
Create Free Account
FOSL2 gene
Known as:
FOS-RELATED ANTIGEN 2
, FOSL2
, FRA2
Expand
This gene is involved in cellular proliferation and apoptosis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Cell Differentiation process
Cell Proliferation
FOSL2 protein, human
Fos-Related Antigen-2
Expand
Broader (1)
FOS Family Genes
Narrower (1)
FOSL2 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
MicroRNA-155-5p suppresses cardiomyocytes apoptosis induced by hypoxia/reoxygenation via targeting fos-related antigen 2
G. Jin
,
Xue-qiang Guan
,
J. Li
,
Jun Ma
2018
Corpus ID: 80330371
2016
2016
Functional Profiling of Human MeCP2 by Automated Data Comparison Analysis and Computerized Expression Pathway Modeling
I. Kim
,
Shinhae Lee
,
J. Jeong
,
J. Park
,
M. Yoo
,
C. Kim
Healthcare Informatics Research
2016
Corpus ID: 17705846
Objectives Methyl-CpG binding protein 2 (MeCP2) is a ubiquitous epigenetic factor that represses gene expression by modifying…
Expand
2009
2009
Recent findings and perspectives of the vision screen in the German Mouse Clinic
O. Puk
,
J. Favor
,
Minxuan Sun
,
C. Dalke
,
J. Graw
2009
Corpus ID: 72768237
Purpose The purpose of this study was the large-scale screening of different mouse models for eye disorders. Methods The…
Expand
2000
2000
Identification of genes responsive to BPDE treatment in HeLa cells using cDNA expression assays
Zhe Yu
,
B. Ford
,
B. Glickman
Environmental and Molecular Mutagenesis
2000
Corpus ID: 19391792
Genotoxic stresses induce cellular responses that can be observed at the level of gene expression. We have studied changes in…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE